| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $29.1M | -76.7% |
| R&D Expense | $550.4M | +9.7% |
| SG&A Expense | $591.4M | -14.0% |
| Operating Income | -$1.00B | -123.7% |
| Pre-tax Income | -$681.6M | -116.0% |
| Income Tax | $48.2M | +116.8% |
| Net Income | -$172.0M | -104.0% |
| EPS (Basic) | -$0.24 | -104.3% |
| EPS (Diluted) | -$0.24 |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.72B | -58.5% |
| Short-term Investments | $2.17B | — |
| Current Assets | $5.00B | -25.7% |
| Total Assets | $5.44B | -24.7% |
| Current Liabilities | $149.4M | -44.0% |
| Total Liabilities | $249.7M | -67.7% |
| Stockholders' Equity | $4.69B | -21.5% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$839.5M | -9.7% |
| Capital Expenditures | $4.6M | +232.8% |
| Investing Cash Flow | -$1.77B | -133.9% |
| Financing Cash Flow | -$1.22B | -390.9% |
| Free Cash Flow | -$844.0M | -10.1% |
| -104.6% |